NOV 18, 2021 7:00 AM PST

Could Maternal Antibodies Contribute to Autism Development?

WRITTEN BY: Tara Fernandez

Pregnant mothers pass on oxygen and nutrients to their developing babies while shuttling away waste products from the fetal blood via the placenta. Mothers also help support fetal immunity by providing them with protective antibodies. However, new research indicates that a particular form of antibodies known as auto-antibodies may move from mother to child and influence their developing brains.

Previous studies have shown that women with children who have received autism diagnoses are more likely to have autoantibodies capable of reacting with proteins in the neural tissues of the fetal brain. Autoantibodies may then trigger changes that set the baby’s brain on a path to autism.

Autism spectrum disorder (ASD) is a condition linked to impaired brain development, which has knock-on effects on an individual’s ability to communicate and socialize. People with ASD also tend to have limited and repetitive patterns of behavior.

Fascinatingly, studies in rhesus monkeys also echo these effects. Animals exposed to maternal autoantibodies in the womb later display altered brain development and abnormal social behaviors.

Now, unpublished studies presented at the 2021 Society for Neuroscience annual meeting provide additional support towards the hypothesis that autoantibodies shape brain development.

In one of these investigations, researchers induced female mice to produce autoantibodies against the CASPR2 protein encoded by a gene called CNTNAP2. This gene has been found to be linked to a variety of neurological conditions, including ASD and epilepsy.

Male offspring of these mice displayed many ASD-like behaviors, including decreased sociability, and showed evidence of atypical neurons in the brain region involved in learning and memory. The researchers found that the presence of maternal autoantibodies sent microglia—resident immune cells of the brain—into overdrive, significantly altering the course of normal brain development.

Ultimately, these and a growing number of studies looking more closely at developmental neuroimmunology could open up many new avenues for understanding the molecular basis of ASD.


 

About the Author
  • Tara Fernandez has a PhD in Cell Biology and has spent over a decade uncovering the molecular basis of diseases ranging from skin cancer to obesity and diabetes. She currently works on developing and marketing disruptive new technologies in the biotechnology industry. Her areas of interest include innovation in molecular diagnostics, cell therapies, and immunology. She actively participates in various science communication and public engagement initiatives to promote STEM in the community.
You May Also Like
SEP 02, 2021
Immunology
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
SEP 02, 2021
Will an Extra COVID Vaccine Shot Benefit People With Autoimmune Conditions?
The global rollout of COVID-19 vaccines has helped save countless lives during the pandemic. Studies have shown that vac ...
SEP 07, 2021
Health & Medicine
Vaccines- a Long History of Cost-Benefit Analysis
SEP 07, 2021
Vaccines- a Long History of Cost-Benefit Analysis
Vaccination and new treatments for diseases have remained topics of skepticism since their inception. When it came to an ...
SEP 12, 2021
Coronavirus
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
SEP 12, 2021
Real-World, Post-Delta COVID-19 Vaccine Data & Potential Treatment
New research may have identified a potential treatment or preventive medication for SARS-CoV-2 and other viral infection ...
SEP 23, 2021
Immunology
Enhanced Hamster Cells as Super Drug Factories
SEP 23, 2021
Enhanced Hamster Cells as Super Drug Factories
Antibodies are highly specialized proteins produced by the immune system that stick on to foreign invaders in the body w ...
OCT 05, 2021
Immunology
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
OCT 05, 2021
Inflammation Overload Triggers 'Microclots' in COVID Long-Haulers
Months after COVID symptoms have subsided, some individuals continue to grapple with the lingering effects of the infect ...
NOV 18, 2021
Immunology
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
NOV 18, 2021
Ultrasound Helps Shuttle Cancer-Killing Antibodies to the Brain
Antibody therapies harness the immune system's power to fight a broad spectrum of diseases, from cancer to infectiou ...
Loading Comments...